Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline can... Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. Mehr anzeigen
Significant Demand for Amtagvi™ (Lifileucel) Continues with $58.6M in Total 3Q24 Product Revenue Reaffirming Guidance of $160-$165M for FY24 and $450-$475M for FY25 of Total Product Revenue...
SAN CARLOS, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.41 | -4.75086906141 | 8.63 | 8.7 | 7.98 | 10552921 | 8.245935 | CS |
| 4 | -2.41 | -22.6716839135 | 10.63 | 12.505 | 7.98 | 8766918 | 9.9532671 | CS |
| 12 | -3.21 | -28.0839895013 | 11.43 | 12.505 | 7.98 | 6262993 | 9.92932663 | CS |
| 26 | -2.07 | -20.1166180758 | 10.29 | 12.505 | 7.11 | 6689168 | 9.39542019 | CS |
| 52 | 2.88 | 53.9325842697 | 5.34 | 18.33 | 5.24 | 7399519 | 10.47873144 | CS |
| 156 | -10.61 | -56.3462559745 | 18.83 | 20.6 | 3.21 | 5247254 | 9.34647575 | CS |
| 260 | -13.81 | -62.6872446664 | 22.03 | 54.2081 | 3.21 | 3889321 | 13.16247187 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
